Stay updated on Neurobiol Basis of Response to Vyvanse in Adults With ADHD: Clinical Trial
Sign up to get notified when there's something new on the Neurobiol Basis of Response to Vyvanse in Adults With ADHD: Clinical Trial page.

Latest updates to the Neurobiol Basis of Response to Vyvanse in Adults With ADHD: Clinical Trial page
- Check4 days agoChange DetectedThe study record page displays a 403 Forbidden message, while a site-wide NIH notice announces a transition in terminology from “Artificial Intelligence” to “Super Intelligence.”SummaryDifference2%

- Check11 days agoChange DetectedThe 403 Forbidden message and its Home link are no longer displayed, leaving the area beneath the navigation blank.SummaryDifference0.5%

- Check18 days agoChange DetectedThe ClinicalTrials.gov footer revision label changes from v3.7.0 to v3.7.1 while the study page continues to display a 403 error.SummaryDifference0.2%

- Check32 days agoChange DetectedThe study record page now displays a 403 Forbidden screen with minimal navigation (Home), and the previous study details and related metadata have been removed.SummaryDifference18%

- Check39 days agoChange DetectedThe page shows a revision tag update from v3.6.6 to v3.7.0, indicating a newer build or update of the page without altering the displayed study information.SummaryDifference0.1%

- Check53 days agoChange DetectedThe page’s revision label was updated from v3.6.5 to v3.6.6 in the metadata, indicating a minor update.SummaryDifference0.1%

Stay in the know with updates to Neurobiol Basis of Response to Vyvanse in Adults With ADHD: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Neurobiol Basis of Response to Vyvanse in Adults With ADHD: Clinical Trial page.